Table of Contents
ISRN Endocrinology
Volume 2013, Article ID 407452, 5 pages
http://dx.doi.org/10.1155/2013/407452
Clinical Study

Diagnostic Value of the Combined Measurement of Serum Hcy, Serum Cys C, and Urinary Microalbumin in Type 2 Diabetes Mellitus with Early Complicating Diabetic Nephropathy

1Department of Clinical Medicine, Taishan Medical College, Tai’an, China
2Department of Clinical Medicine, Shandong University School of Medicine, Ji’nan, China
3Department of Laboratory Medicine, Shandong University Qilu Hospital, Ji’nan 250012, China
4Department of Laboratory Medicine, The Third People’s Hospital, Ji’nan, China
5Department of Laboratory Medicine, Ji’nan Iron and Steel Group Corporation General Hospital, Ji’nan, China

Received 13 July 2013; Accepted 21 August 2013

Academic Editors: E. Hajduch and C. G. Scanes

Copyright © 2013 Tengkai Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Sämann and G. Wolf, “Diabetic nephropathy,” Internist, vol. 53, no. 10, pp. 1195–1206, 2012. View at Google Scholar
  2. J. Menne and H. Haller, “Diabetic nephropathy,” Internist, vol. 52, no. 5, pp. 495–504, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Waśkiewicz, E. Sygnowska, and G. Broda, “Homocysteine concentration and the risk of death in the adult Polish population,” Kardiologia Polska, vol. 70, no. 9, pp. 897–902, 2012. View at Google Scholar
  4. M. Kerkeni, A. Letaief, A. Achour, A. Miled, F. Trivin, and K. Maaroufi, “Hyperhomocysteinemia, paraoxonase concentration and cardiovascular complications in Tunisian patients with nondiabetic renal disease,” Clinical Biochemistry, vol. 42, no. 9, pp. 777–782, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Karabag, A. Kaya, A. Temizhan, F. Koç, S. Yavuz, and S. Çam, “The influence of homocysteine levels on endothelial function and their relation with microvascular complications in T2DM patients without macrovascular disease,” Acta Diabetologica, vol. 44, no. 2, pp. 69–75, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. P. E. Lazzerini, P. L. Capecchi, E. Selvi et al., “Hyperhomocysteinemia: a cardiovascular risk factor in autoimmune diseases?” Lupus, vol. 16, no. 11, pp. 852–862, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Hillenbrand, A. Hillenbrand, F. Liewald, and J. Zimmermann, “Hyperhomocysteinemia and recurrent carotid stenosis,” BMC Cardiovascular Disorders, vol. 8, article 1, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. P. E. Lazzerini, P. L. Capecchi, E. Selvi et al., “Hyperhomocysteinemia, inflammation and autoimmunity,” Autoimmunity Reviews, vol. 6, no. 7, pp. 503–509, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. U. Alehagen, U. Dahlström, and T. L. Lindahl, “Cystatin C and NT-proBNP, a powerful combination of biomarkers for predicting cardiovascular mortality in elderly patients with heart failure: results from a 10-year study in primary care,” European Journal of Heart Failure, vol. 11, no. 4, pp. 354–360, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Naruse, J. Ishii, T. Kawai et al., “Cystatin C in acute heart failure without advanced renal impairment,” American Journal of Medicine, vol. 122, no. 6, pp. 566–573, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Y. Campbell, W. Clarke, H. Park, N. Haq, B. B. Barone, and D. J. Brotman, “Usefulness of cystatin C and prognosis following admission for acute heart failure,” American Journal of Cardiology, vol. 104, no. 3, pp. 389–392, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Kim, “Managing women with gestational diabetes mellitus in the postnatal period,” Diabetes, Obesity and Metabolism, vol. 12, no. 1, pp. 20–25, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Haneda, “Diabetic nephropathy: diagnostic criteria and staging,” Nihon Rinsho Geka Gakkai Zasshi, vol. 63, supplement 6, pp. 320–323, 2005. View at Google Scholar · View at Scopus
  14. M. Horio, E. Imai, Y. Yasuda, T. Watanabe, and S. Matsuo, “Performance of serum cystatin C versus serum creatinine as a marker of glomerular filtration rate as measured by inulin renal clearance,” Clinical and Experimental Nephrology, vol. 15, no. 6, pp. 868–876, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. O. O. Işıklar, B. Barutcuoğlu, C. Kabaroğlu et al., “Do cardiac risk factors affect the homocysteine and asymmetric dimethylarginine relationship in patients with coronary artery diseases?” Clinical Biochemistry, vol. 45, no. 16-17, pp. 1325–1330, 2012. View at Publisher · View at Google Scholar
  16. T. Huang, S. Asimi, D. Lou, and D. Li, “Plasma phospholipid polyunsaturated fatty acids and homocysteine in Chinese type 2 diabetes patients,” Asia Pacific Journal of Clinical Nutrition, vol. 21, no. 3, pp. 394–399, 2012. View at Google Scholar
  17. Z. Banecka-Majkutewicz, W. Sawula, L. Kadziński, A. Węgrzyn, and B. Banecki, “Homocysteine, heat shock proteins, genistein and vitamins in ischemic stroke—pathogenic and therapeutic implications,” Acta Biochimica Polonica, vol. 59, no. 4, pp. 495–499, 2012. View at Google Scholar
  18. B. Ozmen, D. Ozmen, N. Turgan, S. Habif, I. Mutaf, and O. Bayindir, “Association between homocysteinemia and renal function in patients with type 2 diabetes mellitus,” Annals of Clinical and Laboratory Science, vol. 32, no. 3, pp. 279–286, 2002. View at Google Scholar · View at Scopus
  19. C. Zoccali and K. J. Jager, “Hyperhomocysteinemia: a renal and cardiovascular risk factor?” Nature Reviews. Nephrology, vol. 6, no. 12, pp. 695–696, 2010. View at Google Scholar · View at Scopus
  20. V. A. Fonseca, L. M. Fink, and P. A. Kern, “Insulin sensitivity and plasma homocysteine concentrations in non-diabetic obese and normal weight subjects,” Atherosclerosis, vol. 167, no. 1, pp. 105–109, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Hucks, R. C. Thuraisingham, M. J. Raftery, and M. M. Yaqoob, “Homocysteine induced impairment of nitric oxide-dependent vasorelaxation is reversible by the superoxide dismutase mimetic TEMPOL,” Nephrology Dialysis Transplantation, vol. 19, no. 8, pp. 1999–2005, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Jin, R. B. Caldwell, T. Li-Masters, and R. W. Caldwell, “Homocysteine induces endothelial dysfunction via inhibition of arginine transport,” Journal of Physiology and Pharmacology, vol. 58, no. 2, pp. 191–206, 2007. View at Google Scholar · View at Scopus
  23. T.-H. Lan, Z.-W. Xu, Z. Wang, Y.-L. Wu, W.-K. Wu, and H.-M. Tan, “Ginsenoside Rb1 prevents homocysteine-induced endothelial dysfunction via PI3K/Akt activation and PKC inhibition,” Biochemical Pharmacology, vol. 82, no. 2, pp. 148–155, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Araki, “Homocysteine and diabetic macroangiopathy,” Nihon Rinsho Geka Gakkai Zasshi, vol. 64, no. 11, pp. 2153–2158, 2006. View at Google Scholar · View at Scopus
  25. P. Delanaye, E. Cavalier, O. Moranne, L. Lutteri, J. M. Krzesinski, and O. Bruyère, “Creatinine-or cystatin C-based equations to estimate glomerular filtration in the general population: impact on the epidemiology of chronic kidney disease,” BMC Nephrology, vol. 14, no. 1, article 57, 2013. View at Google Scholar
  26. M. Horio, E. Imai, Y. Yasuda, T. Watanabe, and S. Matsuo, “GFR estimation using standardized serum cystatin C in Japan,” American Journal of Kidney Diseases, vol. 61, no. 2, pp. 197–203, 2013. View at Publisher · View at Google Scholar
  27. J. S. Kim, M. K. Kim, J. Y. Lee, B. G. Han, S. O. Choi, and J. W. Yang, “The effects of proteinuria on urinary cystatin-C and glomerular filtration rate calculated by serum cystatin-C,” Renal Failure, vol. 34, no. 6, pp. 676–684, 2012. View at Publisher · View at Google Scholar
  28. P. K. Dabla, “Renal function in diabetic nephropathy,” World Journal of Diabetes, vol. 1, no. 2, pp. 48–56, 2010. View at Google Scholar